Free provider profile
SAMUEL WILKINSON, M.D.
NPI 1265736169
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2015-09-30.
20 YORK ST # T-209 YALE-NEW HAVEN HOSPITAL, NEW HAVEN, CT, 06510
203-688-9503
Single practice location
Enumerated 2011-01-06
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 11 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
113
Medicare patients
26
Part D drug cost
$2,178
Brand-name share
Not published
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Duloxetine Hcl (Duloxetine Hcl) | 13 | $224 |
| Clonazepam (Clonazepam) | 27 | $168 |
| Dextroamphetamine-Amphet Er (Dextroamphetamine/Amphetamine) | 11 | $159 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202321 sessions · 11 patients · $535
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.